In Vivo efficacy assessment of the CDK4/6 inhibitor palbociclib and the PLK1 inhibitor volasertib in Human Chordoma Xenografts [Target-seq]
收藏NIAID Data Ecosystem2026-03-14 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP404208
下载链接
链接失效反馈官方服务：
资源简介：
Analysis of gene mutations and copy number variation status by an in-house next-generation sequencing (NGS) panel. The panel includes 571 genes of interest in oncology for diagnosis, prognosis, and theranostics including chordomas genes of interest. Overall design: Three chordoma Patient's Derived Xenograft (PDX) models (CD3, CD7 and CD39) and corresponding germline samples were analyzed.
创建时间：
2023-01-05
